CardioComm Solutions, Inc. (TSX VENTURE:EKG) ("CardioComm Solutions"

or the "Company") today announced the limited release of its new

proprietary GEMS? Air software, electrocardiogram ("ECG") SDK viewer

(GUAVA?) and a new customized web-based device interface. The pre

GEMS? 4.0 version will be incorporated into wireless arrhythmia

services for the remote diagnostic arrhythmia and remote patient

monitoring market.

The new GEMS? Air software solution was designed to simplify the work

flow associated with real-time, wireless cardiac monitoring. While

broad commercial release of GEMS? 4.0 is scheduled for later this

year, Philips Healthcare and TZ Medical have leveraged this limited

advanced version of the software, along with its customized web-based

device interface, in their remote diagnostic arrhythmia monitoring

technology and services. Both companies will each separately announce

their product debuts during the Heart Rhythm 2012 Annual Scientific

Sessions in Boston, MA.

"CardioComm Solutions is continuing to strengthen its alliances with

many Tier 1 health service leaders," said Dr. Anatoly Langer, Chairman

of CardioComm Solutions' Board. "Our ongoing work with international

medical technology companies is a critical part of this long term

strategy. This newest of our GEMS? based software technology advances

is already of significant interest to medical companies that possess

large global sales and marketing networks and that possess, or can

access, existing relationships with the world's cardiologists,

hospitals and monitoring services," Dr. Langer added.

"For the past three years CardioComm Solutions has been compiling new

GEMS? and GUAVA? solutions to enable the integration of multiple ECG

recording and transmitting devices that have received FDA market

clearance, Health Canada Medical Device Licensure, as well as the

European CE Mark for medical devices. This release marks another

important milestone in achieving that objective," noted Etienne Grima,

Chief Executive Officer of CardioComm Solutions. "CardioComm Solutions

continues to demonstrate that we are an innovative solutions provider

that meets the business and medical care challenges associated with

the growing ECG monitoring markets."

"CardioComm Solutions has developed the most advanced connectivity

option between device and medical call centre. Their GEMS? software is

the engine behind the launch of the AERA CT mobile Cardiac telemetry

(MCT) device and will be part of the international marketing efforts

of TZ Medical," stated John Lubisich, President, TZ Medical, Inc.

"CardioComm Solutions has worked with Philips as a preferred provider

of ECG interfaces and management tools for many years within the

cardiac monitoring service environment," said Martha Dolan, Marketing

Director, Philips Remote Cardiac Services. "With their logical

approach to solutions development and their on-time business delivery,

CardioComm Solutions has proven to be a reliable provider in support

of our goal to improve the lives of our patients."

The global Cardiovascular Monitoring and Diagnostic devices market is

forecast to reach US$12 billion by 2015 with the North American

segment accounting for approximately 40%, Europe more than 25% and

Asia-Pacific as the fastest growing region driving a value of US$3.4

billion. "These early start US based strategic relationships highlight

the opportunities that can be replicated in Canada, South America and

overseas by leveraging CardioComm Solutions' multi-country client

base," adds Mr. Grima.

About CardioComm Solutions

CardioComm Solution's patented and proprietary technology is used in

products for recording, viewing, analyzing and storing

electrocardiograms (ECGs) for diagnosis and management of cardiac

patients. Products are sold worldwide through a combination of an

external distribution network and a North American-based sales team.

The company has earned the ISO 13485 certification, is HPB approved,

HIPAA compliant, and has received FDA market clearance for its

software devices. CardioComm Solutions, Inc. is headquartered in

Toronto, Canada, with offices in Victoria, B.C.

Forward-Looking Statements

This release may contain certain forward-looking statements with

respect to the financial condition, results of operations and business

of CardioComm Solutions and certain of the plans and objectives of

CardioComm Solutions with respect to these items. By their nature,

forward-looking statements involve risk and uncertainty because they

relate to events and depend on circumstances that will occur in the

future and there are many factors that could cause actual results and

developments to differ materially from those expressed or implied by

these forward-looking statements.

Neither TSX Venture Exchange nor its Regulation Services Provider (as

that term is defined in policies of the TSX Venture Exchange) accepts

responsibility for the adequacy or accuracy of this release